| Bluegrass Hearing Clinic, Llc | |
|
116 Meridian Way Ste 1, Richmond, KY 40475-2876 | |
| (859) 623-4458 | |
| (859) 623-4459 |
| Full Name | Bluegrass Hearing Clinic, Llc |
|---|---|
| Type | Facility |
| Speciality | Audiologist - Assistive Technology Practitioner |
| Location | 116 Meridian Way Ste 1, Richmond, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942489976 | NPI | - | NPPES |
| 000000041650 | Other | KY | ANTHEM |
| 70006507 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231HA2400X | Audiologist - Assistive Technology Practitioner | (* (Not Available)) | Primary |
| Provider Name | Deanna L Frazier |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1508861048 PECOS PAC ID: 9133010853 Enrollment ID: I20040323000383 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Stacey A High |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1619124617 PECOS PAC ID: 4082750625 Enrollment ID: I20091012000450 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Vanessa L Ewert |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1790049781 PECOS PAC ID: 5698901734 Enrollment ID: I20131120001587 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Lucinda Kerr Batta |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1245600667 PECOS PAC ID: 1850692039 Enrollment ID: I20151211001406 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Shelley T Heath |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1417486580 PECOS PAC ID: 5597033191 Enrollment ID: I20170623000890 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Mary Sohler |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1376100982 PECOS PAC ID: 6709110653 Enrollment ID: I20190626001268 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Kari Ann Wickstrom |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1104317221 PECOS PAC ID: 3779836366 Enrollment ID: I20210126002981 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Helena R Pinheiro |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1790377372 PECOS PAC ID: 8921474933 Enrollment ID: I20221017001268 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Kara Kerns |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1578252714 PECOS PAC ID: 8628438082 Enrollment ID: I20230717001780 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Provider Name | Michaela Jiunta |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1669160263 PECOS PAC ID: 9638530041 Enrollment ID: I20230802000519 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bluegrass Hearing Clinic, Llc 116 Meridian Way Ste 1, Richmond, KY 40475-2876 Ph: (859) 623-4458 | Bluegrass Hearing Clinic, Llc 116 Meridian Way Ste 1, Richmond, KY 40475-2876 Ph: (859) 623-4458 |
News Archive
Indevus Pharmaceuticals and Valera Pharmaceuticals have announced the completion of their previously announced merger, which became effective at 12:01 a.m., April 18, 2007.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector. To celebrate their new relationship with Reuters Insider, PharmaTelevision is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.
Affinium Pharmaceuticals announced today that it has initiated dosing in a Phase 1 intravenous clinical trial of its new antibiotic prodrug, AFN-1720. AFN-1720 is the prodrug of the active drug, AFN-1252.
› Verified 8 days ago
Kari A Wickstrom, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 116 Meridian Way Ste 1, Richmond, KY 40475 Phone: 859-623-4458 Fax: 859-623-4459 | |
Daena C. Wilds, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1036 Amberley Way, Ste. A, Richmond, KY 40475 Phone: 859-623-4458 Fax: 859-623-4459 | |
Shelley Heath, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1036 Amberley Way Ste A, Richmond, KY 40475 Phone: 859-623-4458 Fax: 859-623-4459 | |
Michaela Ann Jiunta, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 116 Meridian Way Ste 1, Richmond, KY 40475 Phone: 859-623-4458 | |
Hear At Your Service Llc Audiologist Medicare: Medicare Enrolled Practice Location: 1036 Amberley Way Ste A, Richmond, KY 40475 Phone: 859-623-4458 Fax: 859-623-4459 |